Apogepha Arzneimittel GmbH is a German pharmaceutical company headquartered in Dresden. With a history spanning over a century, Apogepha focuses on the development, manufacturing, and distribution of medicinal products, particularly in the field of urology. They are known for their commitment to research and innovation, aiming to provide effective treatments and improve patient quality of life. The company emphasizes quality and reliability in its production processes, adhering to stringent pharmaceutical standards as an owner-managed, independent entity.
The Dresden headquarters serves as the central hub for Apogepha's operations, encompassing research and development, manufacturing, quality control, administration, sales, and marketing for its pharmaceutical products.
The facility likely includes specialized GMP (Good Manufacturing Practice) compliant production areas, advanced research and quality control laboratories, and modern office spaces designed to foster scientific collaboration and operational efficiency.
As an established German pharmaceutical company, the work culture at Apogepha likely emphasizes precision, high-quality standards, scientific innovation, and a strong sense of responsibility towards patient health. A collaborative environment between research, production, and commercial teams is essential, with a focus on employee development and adherence to strict regulatory guidelines.
The headquarters is crucial as the operational core of Apogepha, driving its research in urology and other therapeutic areas. It represents the company's long-standing presence in Dresden and its contribution to the German pharmaceutical industry.
While primarily focused on the German market, Apogepha Arzneimittel GmbH extends its reach internationally through a network of distribution partners and licensing agreements. This allows their specialized pharmaceutical products, particularly in urology, to be available in various countries. Key functions supported globally include product distribution, marketing collaborations, and managing regulatory affairs for international markets, ensuring their therapies benefit patients worldwide.
Kyffhäuserstraße 27
Dresden
Saxony (Sachsen)
Germany
Address: N/A
N/A
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, APOGEPHA Arzneimittel GmbH' leadership includes:
APOGEPHA Arzneimittel GmbH has been backed by several prominent investors over the years, including:
Within the past year, Apogepha Arzneimittel GmbH experienced a change in its executive team with the departure of a Managing Director. The company's leadership structure otherwise remained stable with Dr. Dirk Pamperin as CEO and Henriette Bodem as Managing Director.
Discover the tools APOGEPHA Arzneimittel GmbH uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Apogepha Arzneimittel GmbH likely uses common German corporate email patterns, typically combining elements of an employee's name with their domain '@apogepha.de'. The most frequent formats include the first initial followed by the last name, or the full first name followed by the last name, separated by a dot.
Common formats: [first_initial].[last_name]@apogepha.de (e.g., m.mustermann@apogepha.de) or [first_name].[last_name]@apogepha.de (e.g., max.mustermann@apogepha.de)
Format
d.pamperin@apogepha.de
Example
85%
Success rate
Apogepha Arzneimittel GmbH Website • March 07, 2024
Apogepha Arzneimittel GmbH has once again received the 'Work and Family' audit certificate, recognizing its commitment to a family-friendly HR policy and work environment, supporting employees in balancing their professional and private lives....more
Apogepha Arzneimittel GmbH Website • November 27, 2023
Continuing its tradition, Apogepha Arzneimittel GmbH made a donation to Sonnenstrahl e.V. Dresden, an association supporting children and young people with cancer and their families, instead of sending Christmas gifts to business partners....more
Apogepha Arzneimittel GmbH Website • September 04, 2023
Apogepha welcomed new apprentices starting their careers in various fields such as pharmaceutical production (Pharmakant), laboratory work (Chemielaborant), and industrial administration (Industriekaufmann/-frau), highlighting its commitment to vocational training and developing future talent....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including APOGEPHA Arzneimittel GmbH, are just a search away.